Compound atlas
Performance

AICAR

AMPK activator
Half-life
1h
approx. mean t½
Dose range
Research
typical, not prescriptive
Category
Performance
primary use-case
Single-dose decay
t½ = 1h · first-order model
~4h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m1.2h2.4h3.6h4.8h6h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

An AMPK-activating compound studied as an endurance/exercise mimetic in animals. Banned in sport; little human safety data.

Mechanism of action

Mimics AMP to activate AMPK, increasing glucose uptake and fatty-acid oxidation.

Typical protocol

Preclinical; no established human protocol.

Storage

Per formulation; cool, dry.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.